Skip to main content
Top
Published in: The European Journal of Health Economics 8/2015

01-11-2015 | Original Paper

Between-country heterogeneity in EQ-5D-3L scoring algorithms: how much is due to differences in health state selection?

Authors: Eleanor M. Pullenayegum, Kuhan Perampaladas, Kathryn Gaebel, Brett Doble, Feng Xie

Published in: The European Journal of Health Economics | Issue 8/2015

Login to get access

Abstract

Background

EQ-5D-3L scoring algorithms vary amongst countries, not only in the values of regression coefficients but also in the independent variables included in the regression model (hereafter referred to as model specification). It is unclear how much of this variation is due to differences in health state selection, the relative frequencies with which health states were valued, and model diagnostics, rather than to genuine differences in population preferences.

Methods

Using aggregate data from a recent review, we noted all model specifications that were used. For each country the country’s own model was re-fitted, as were all other model specifications. This was done twice: once using all valued health states for each country, and again using a common set of 17 health states for all countries. Goodness of fit was assessed using the following model diagnostics: mean absolute error (MAE), mean squared error (MSE) and rho (the Pearson correlation coefficient between predicted and observed mean utilities), both with and without leave-one-out cross-validation.

Results

Thirteen countries contributed data. Even when using a common set of health states, the preferred model varied across countries. However, choice of health states did impact the preferred model specification: when using cross-validation, the preferred specification changed in five of ten countries when moving from 17 health states to all valued health states. The relative frequency with which health states were valued had little impact on the preferred model.

Conclusions

Variation in choices of health states to value is responsible for some, but not all, of the observed heterogeneity in model specification. Relative frequency of health state valuation and choice of model diagnostic has a limited impact on model preference, however, use of cross-validation has a substantial impact. The use of cross-validation, implemented through omitting health states rather than respondents, is recommended as one approach to assessing model fit.
Appendix
Available only for authorised users
Literature
2.
go back to reference Canadian Agency for Drugs and Technology in Health: Guidelines for economic evaluation of health technologies, 3rd edn. Canadian Agency for Drugs and Technology in Health, Ottawa, ON, Canada (2006) Canadian Agency for Drugs and Technology in Health: Guidelines for economic evaluation of health technologies, 3rd edn. Canadian Agency for Drugs and Technology in Health, Ottawa, ON, Canada (2006)
3.
go back to reference EuroQol–a new facility for the measurement of health-related quality of life.: The EuroQol group. Health Policy. 16, 199–208 (1990) EuroQol–a new facility for the measurement of health-related quality of life.: The EuroQol group. Health Policy. 16, 199–208 (1990)
4.
5.
go back to reference Badia, X., Roset, M., Herdman, M., Kind, P.: A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med. Decis. Making 21, 7–16 (2001)CrossRefPubMed Badia, X., Roset, M., Herdman, M., Kind, P.: A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med. Decis. Making 21, 7–16 (2001)CrossRefPubMed
6.
go back to reference Johnson, J.A., Luo, N., Shaw, J.W., Kind, P., Coons, S.J.: Valuations of EQ-5D health states: are the United States and United Kingdom different? Med. Care 43, 221–228 (2005)CrossRefPubMed Johnson, J.A., Luo, N., Shaw, J.W., Kind, P., Coons, S.J.: Valuations of EQ-5D health states: are the United States and United Kingdom different? Med. Care 43, 221–228 (2005)CrossRefPubMed
7.
go back to reference Tsuchiya, A., Ikeda, S., Ikegami, N., et al.: Estimating an EQ-5D population value set: the case of Japan. Health Econ. 11, 341–353 (2002)CrossRefPubMed Tsuchiya, A., Ikeda, S., Ikegami, N., et al.: Estimating an EQ-5D population value set: the case of Japan. Health Econ. 11, 341–353 (2002)CrossRefPubMed
8.
go back to reference Shaw, J.W., Johnson, J.A., Chen, S., Levin, J.R., Coons, S.J.: Racial/ethnic differences in preferences for the EQ-5D health states: results from the USA valuation study. J. Clin. Epidemiol. 60, 479–490 (2007)CrossRefPubMed Shaw, J.W., Johnson, J.A., Chen, S., Levin, J.R., Coons, S.J.: Racial/ethnic differences in preferences for the EQ-5D health states: results from the USA valuation study. J. Clin. Epidemiol. 60, 479–490 (2007)CrossRefPubMed
9.
go back to reference Shaw, J.W., Johnson, J.A., Coons, S.J.: USA valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med. Care 43, 203–220 (2005)CrossRefPubMed Shaw, J.W., Johnson, J.A., Coons, S.J.: USA valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med. Care 43, 203–220 (2005)CrossRefPubMed
10.
go back to reference Jo, M.W., Yun, S.C., Lee, S.I.: Estimating quality weights for EQ-5D health states with the time trade-off method in South Korea. Value Health 11, 1186–1189 (2008)CrossRefPubMed Jo, M.W., Yun, S.C., Lee, S.I.: Estimating quality weights for EQ-5D health states with the time trade-off method in South Korea. Value Health 11, 1186–1189 (2008)CrossRefPubMed
11.
go back to reference Zarate, V., Kind, P., Valenzuela, P., Vignau, A., Olivares-Tirado, P., Munoz, A.: Social valuation of EQ-5D health states: the Chilean case. Value Health 14, 1135–1141 (2011)CrossRefPubMed Zarate, V., Kind, P., Valenzuela, P., Vignau, A., Olivares-Tirado, P., Munoz, A.: Social valuation of EQ-5D health states: the Chilean case. Value Health 14, 1135–1141 (2011)CrossRefPubMed
12.
go back to reference Macaran S, Kind P.: Valuing EQ-5D health states using a modified MVH protocol. Prelim. Results 16, 205–39 (1999) Macaran S, Kind P.: Valuing EQ-5D health states using a modified MVH protocol. Prelim. Results 16, 205–39 (1999)
13.
go back to reference Lamers, L.M., McDonnell, J., Stalmeier, P.F., Krabbe, P.F., Busschbach, J.J.: The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ. 15, 1121–1132 (2006)CrossRefPubMed Lamers, L.M., McDonnell, J., Stalmeier, P.F., Krabbe, P.F., Busschbach, J.J.: The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ. 15, 1121–1132 (2006)CrossRefPubMed
14.
go back to reference Chuang, L.H., Kind, P.: The effect of health state selection on the valuation of EQ-5D. Med. Decis. Making 31, 186–194 (2011)CrossRefPubMed Chuang, L.H., Kind, P.: The effect of health state selection on the valuation of EQ-5D. Med. Decis. Making 31, 186–194 (2011)CrossRefPubMed
15.
go back to reference Viney, R., Norman, R., King, M.T., et al.: Time trade-off derived EQ-5D weights for Australia. Value Health 14, 928–936 (2011)CrossRefPubMed Viney, R., Norman, R., King, M.T., et al.: Time trade-off derived EQ-5D weights for Australia. Value Health 14, 928–936 (2011)CrossRefPubMed
16.
go back to reference Wittrup-Jensen, K.U., Lauridsen, J., Gudex, C., Pedersen, K.M.: Generation of a Danish TTO value set for EQ-5D health states. Scand. J. Public Health 37, 459–466 (2009)CrossRefPubMed Wittrup-Jensen, K.U., Lauridsen, J., Gudex, C., Pedersen, K.M.: Generation of a Danish TTO value set for EQ-5D health states. Scand. J. Public Health 37, 459–466 (2009)CrossRefPubMed
17.
go back to reference Bansback, N., Tsuchiya, A., Brazier, J., Anis, A.: Canadian valuation of EQ-5D health states: preliminary value set and considerations for future valuation studies. PLoS One 7, e31115 (2012)PubMedCentralCrossRefPubMed Bansback, N., Tsuchiya, A., Brazier, J., Anis, A.: Canadian valuation of EQ-5D health states: preliminary value set and considerations for future valuation studies. PLoS One 7, e31115 (2012)PubMedCentralCrossRefPubMed
18.
go back to reference Golicki, D., Jakubczyk, M., Niewada, M., Wrona, W., Busschbach, J.J.: Valuation of EQ-5D health states in poland: first TTO-based social value set in central and eastern Europe. Value Health 13, 289–297 (2010)CrossRefPubMed Golicki, D., Jakubczyk, M., Niewada, M., Wrona, W., Busschbach, J.J.: Valuation of EQ-5D health states in poland: first TTO-based social value set in central and eastern Europe. Value Health 13, 289–297 (2010)CrossRefPubMed
19.
go back to reference Norman, R., Cronin, P., Viney, R., King, M., Street, D., Ratcliffe, J.: International comparisons in valuing EQ-5D health states: a review and analysis. Value Health 12, 1194–1200 (2009)CrossRefPubMed Norman, R., Cronin, P., Viney, R., King, M., Street, D., Ratcliffe, J.: International comparisons in valuing EQ-5D health states: a review and analysis. Value Health 12, 1194–1200 (2009)CrossRefPubMed
20.
go back to reference Xie F, Gaebel K, Perampaladas K, Doble B, Pullenayegum EM.: Comparing EQ-5D valuation studies: a systematic review and methodological reporting checklist. Med. Decis. Making 22 Mar 2013 (epub ahead of print) Xie F, Gaebel K, Perampaladas K, Doble B, Pullenayegum EM.: Comparing EQ-5D valuation studies: a systematic review and methodological reporting checklist. Med. Decis. Making 22 Mar 2013 (epub ahead of print)
21.
go back to reference Augustovski, F.A., Irazola, V.E., Velazquez, A.P., Gibbons, L., Craig, B.M.: Argentine valuation of the EQ-5D health states. Value Health 12, 587–596 (2009)CrossRefPubMed Augustovski, F.A., Irazola, V.E., Velazquez, A.P., Gibbons, L., Craig, B.M.: Argentine valuation of the EQ-5D health states. Value Health 12, 587–596 (2009)CrossRefPubMed
22.
go back to reference Chevalier J, de Pouvourville G.: Valuing EQ-5D using time trade-off in France. Eur. J. Health. Econ. (2011) Chevalier J, de Pouvourville G.: Valuing EQ-5D using time trade-off in France. Eur. J. Health. Econ. (2011)
23.
go back to reference Greiner, W., Claes, C., Busschbach, J.J., von der Schulenburg, J.M.: Validating the EQ-5D with time trade-off for the German population. Eur. J. Health. Econ. 6, 124–130 (2005)CrossRefPubMed Greiner, W., Claes, C., Busschbach, J.J., von der Schulenburg, J.M.: Validating the EQ-5D with time trade-off for the German population. Eur. J. Health. Econ. 6, 124–130 (2005)CrossRefPubMed
25.
go back to reference Kind, P.: Valuing health benefits using the EQ-5D: the West Lothian question. In: Stavem, K. (ed.) 22nd Plenary meeting of the EuroQol Group, Oslo, Norway, pp. 55–77 (2005) Kind, P.: Valuing health benefits using the EQ-5D: the West Lothian question. In: Stavem, K. (ed.) 22nd Plenary meeting of the EuroQol Group, Oslo, Norway, pp. 55–77 (2005)
26.
go back to reference Shaw, J.W., Pickard, A.S., Yu, S., et al.: A median model for predicting United States population-based EQ-5D health state preferences. Value Health 13, 278–288 (2010)CrossRefPubMed Shaw, J.W., Pickard, A.S., Yu, S., et al.: A median model for predicting United States population-based EQ-5D health state preferences. Value Health 13, 278–288 (2010)CrossRefPubMed
27.
go back to reference Zarate, V., Kind, P., Chuang, L.H.: Hispanic valuation of the EQ-5D health states: a social value set for Latin Americans. Value Health 11, 1170–1177 (2008)CrossRefPubMed Zarate, V., Kind, P., Chuang, L.H.: Hispanic valuation of the EQ-5D health states: a social value set for Latin Americans. Value Health 11, 1170–1177 (2008)CrossRefPubMed
28.
go back to reference Chang, T.J., Tarn, Y.H., Hsieh, C.L., Liou, W.S., Shaw, J.W., Chiou, X.G.: Taiwanese version of the EQ-5D: validation in a representative sample of the Taiwanese population. J. Formos. Med. Assoc. 106, 1023–1031 (2007)CrossRefPubMed Chang, T.J., Tarn, Y.H., Hsieh, C.L., Liou, W.S., Shaw, J.W., Chiou, X.G.: Taiwanese version of the EQ-5D: validation in a representative sample of the Taiwanese population. J. Formos. Med. Assoc. 106, 1023–1031 (2007)CrossRefPubMed
Metadata
Title
Between-country heterogeneity in EQ-5D-3L scoring algorithms: how much is due to differences in health state selection?
Authors
Eleanor M. Pullenayegum
Kuhan Perampaladas
Kathryn Gaebel
Brett Doble
Feng Xie
Publication date
01-11-2015
Publisher
Springer Berlin Heidelberg
Published in
The European Journal of Health Economics / Issue 8/2015
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-014-0633-1

Other articles of this Issue 8/2015

The European Journal of Health Economics 8/2015 Go to the issue